Glucocorticoid Signaling in Health and Disease

NeuroImmune Biology

Volumn 7, Issue C, 2007, Pages 33-53

  Smoak, Kathleen A ^a   Cidlowski, John A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957809215     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(07)00203-7     Document Type: Review

References (133)

1. Glyn J. The discovery and early use of cortisone. J R Soc Med 91 10 (1998) 513-517
2. Hench P., Slocumb C.H., and Polley H.F. The effect of a hormone of the adrenal cortex (17-Hydroxy-11-Dehydrocorticosterone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Rochester, MN. Proc Staff Meet Mayo Clin 24 8 (1949) 187-197
3. Carryer H.M., Koelsche G.A., Prickman L.E., Maytum C.K., Lake C.F., and Williams H.L. The effect of cortisone of bronchial asthma and hay fever occurring in subjects sensitive to ragweed pollen. J Allergy 21 4 (1950) 282-287
4. Cole T.J., Blendy J.A., Monaghan A.P., Krieglstein K., Schmid W., Aguzzi A., et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9 13 (1995) 1608-1621
5. Robinson-Rechavi M., Carpentier A.S., Duffraisse M., and Laudet V. How many nuclear hormone receptors are there in the human genome. Trends Genet 17 10 (2001) 554-556
6. Lewis-Tuffin L.J., Jewell C.M., Bienstock R.J., Collins J.B., and Cidlowski J.A. The human glucocorticoid receptor {beta} (hGR{beta}) Binds RU-486 and is transcriptionally active. Mol Cell Biol 27 6 (2007) 2266-2282
7. Charmandari E., Chrousos G.P., Ichijo T., Bhattacharyya N., Vottero A., Souvatzoglou E., et al. The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes. Mol Endocrinol 19 1 (2005) 52-64
8. Oakley R.H., Jewell C.M., Yudt M.R., Bofetiado D.M., and Cidlowski J.A. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J Biol Chem 274 39 (1999) 27857-27866
9. Yudt M.R., Jewell C.M., Bienstock R.J., and Cidlowski J.A. Molecular origins for the dominant negative function of human glucocorticoid receptor beta. Mol Cell Biol 23 12 (2003) 4319-4330
10. Leung D.Y., Hamid Q., Vottero A., Szefler S.J., Surs W., Minshall E., et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med 186 9 (1997) 1567-1574
11. Chikanza I.C. Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform. Ann N Y Acad Sci 966 (2002) 39-48
12. Honda M., Orii F., Ayabe T., Imai S., Ashida T., Obara T., et al. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118 5 (2000) 859-866
13. Lu N.Z., and Cidlowski J.A. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 18 3 (2005) 331-342
14. Yudt M.R., and Cidlowski J.A. Molecular identification and characterization of a and b forms of the glucocorticoid receptor. Mol Endocrinol 15 7 (2001) 1093-1103
15. Lu N.Z., and Cidlowski J.A. Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol 16 6 (2006) 301-307
16. Kumar R., and Thompson E.B. Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions. Mol Endocrinol 17 1 (2003) 1-10
17. Coghlan M.J., Elmore S.W., Kym P.R., and Kort M.E. The pursuit of differentiated ligands for the glucocorticoid receptor. Curr Top Med Chem 3 14 (2003) 1617-1635
18. Kumar R., and Thompson E.B. The structure of the nuclear hormone receptors. Steroids 64 5 (1999) 310-319
19. Dittmar K.D., Banach M., Galigniana M.D., and Pratt W.B. The role of DnaJ-like proteins in glucocorticoid receptor.hsp90 heterocomplex assembly by the reconstituted hsp90.p60.hsp70 foldosome complex. J Biol Chem 273 13 (1998) 7358-7366
20. Dittmar K.D., Demady D.R., Stancato L.F., Krishna P., and Pratt W.B. Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor.hsp90 heterocomplexes formed by hsp90.p60.hsp70. J Biol Chem 272 34 (1997) 21213-21220
21. Schoneveld O.J., Gaemers I.C., and Lamers W.H. Mechanisms of glucocorticoid signalling. Biochim Biophys Acta 1680 2 (2004) 114-128
22. Wieland S., Schatt M.D., and Rusconi S. Role of TATA-element in transcription from glucocorticoid receptor-responsive model promoters. Nucleic Acids Res 18 17 (1990) 5113-5118
23. Jantzen H.M., Strahle U., Gloss B., Stewart F., Schmid W., Boshart M., et al. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 49 1 (1987) 29-38
24. Kassel O., Sancono A., Kratzschmar J., Kreft B., Stassen M., and Cato A.C. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. EMBO J 20 24 (2001) 7108-7116
25. Barnes P.J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 94 6 (1998) 557-572
26. De Bosscher K., Vanden Berghe W., and Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappa B or activator protein-1. Molecular mechanisms for gene repression. Endocr Rev 24 4 (2003) 488-522
27. Drouin J., Sun Y.L., Chamberland M., Gauthier Y., De Lean A., Nemer M., et al. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J 12 1 (1993) 145-156
28. Morrison N., and Eisman J. Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter. J Bone Miner Res 8 8 (1993) 969-975
29. Meyer T., Carlstedt-Duke J., and Starr D.B. A weak TATA box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene. J Biol Chem 272 49 (1997) 30709-30714
30. Philips A., Maira M., Mullick A., Chamberland M., Lesage S., Hugo P., et al. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol Cell Biol 17 10 (1997) 5952-5959
31. Chandran U.R., Warren B.S., Baumann C.T., Hager G.L., and DeFranco D.B. The glucocorticoid receptor is tethered to DNA-bound Oct-1 at the mouse gonadotropin-releasing hormone distal negative glucocorticoid response element. J Biol Chem 274 4 (1999) 2372-2378
32. Novac N., Baus D., Dostert A., and Heinzel T. Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter. FASEB J 20 8 (2006) 1074-1081
33. Almawi W.Y., and Melemedjian O.K. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 71 1 (2002) 9-15
34. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl (2002) S81-S96
35. McKay L.I., and Cidlowski J.A. Cross-talk between nuclear factor-kappa B the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 12 1 (1998) 45-56
36. McKay L.I., and Cidlowski J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 20 4 (1999) 435-459
37. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., et al. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 122 5 (2005) 707-721
38. Eddleston J., Herschbach J., Wagelie-Steffen A.L., Christiansen S.C., and Zuraw B.L. The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J Allergy Clin Immunol 119 1 (2007) 115-122
39. Marco B.D., Massetti M., Bruscoli S., Macchiarulo A., Virgilio R.D., Velardi E., et al. Glucocorticoid-induced leucine zipper (GILZ)/NF-kappa B interaction: role of GILZ homo-dimerization and C-terminal domain. Nucleic Acids Res 35 2 (2006) 517-528
40. McKay L.I., and Cidlowski J.A. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 14 8 (2000) 1222-1234
41. Tao Y., Williams-Skipp C., and Scheinman R.I. Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis. J Biol Chem 276 4 (2001) 2329-2332
42. Nissen R.M., and Yamamoto K.R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 14 18 (2000) 2314-2329
43. Li J., Lin Q., Yoon H.G., Huang Z.Q., Strahl B.D., Allis C.D., et al. Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Mol Cell Biol 22 16 (2002) 5688-5697
44. Fletcher T.M., Ryu B.W., Baumann C.T., Warren B.S., Fragoso G., John S., et al. Structure and dynamic properties of a glucocorticoid receptor-induced chromatin transition. Mol Cell Biol 20 17 (2000) 6466-6475
45. Belikov S., Gelius B., Almouzni G., and Wrange O. Hormone activation induces nucleosome positioning in vivo. EMBO J 19 5 (2000) 1023-1033
46. Ito K., Yamamura S., Essilfie-Quaye S., Cosio B., Ito M., Barnes P.J., et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 203 1 (2006) 7-13
47. Leis H., Page A., Ramirez A., Bravo A., Segrelles C., Paramio J., et al. Glucocorticoid receptor counteracts tumorigenic activity of Akt in skin through interference with the phosphatidylinositol 3-kinase signaling pathway. Mol Endocrinol 18 2 (2004) 303-311
48. Doucas V., Shi Y., Miyamoto S., West A., Verma I., and Evans R.M. Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 97 22 (2000) 11893-11898
49. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 5600 (2002) 1911-1912
50. Schule R., Rangarajan P., Kliewer S., Ransone L.J., Bolado J., Yang N., et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62 6 (1990) 1217-1226
51. Mittelstadt P.R., and Ashwell J.D. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 276 31 (2001) 29603-29610
52. Caelles C., Gonzalez-Sancho J.M., and Munoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev 11 24 (1997) 3351-3364
53. Bruna A., Nicolas M., Munoz A., Kyriakis J.M., and Caelles C. Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. EMBO J 22 22 (2003) 6035-6044
54. Aittomaki S., Pesu M., Groner B., Janne O.A., Palvimo J.J., and Silvennoinen O. Cooperation among Stat1, glucocorticoid receptor,PU. 1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes. J Immunol 164 11 (2000) 5689-5697
55. Takeda T., Kurachi H., Yamamoto T., Nishio Y., Nakatsuji Y., Morishige K., et al. Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid. J Endocrinol 159 2 (1998) 323-330
56. Fuller G.M., and Zhang Z. Transcriptional control mechanism of fibrinogen gene expression. Ann N Y Acad Sci 936 (2001) 469-479
57. Zhang Z., Jones S., Hagood J.S., Fuentes N.L., and Fuller G.M. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J Biol Chem 272 49 (1997) 30607-30610
58. Lavrovsky Y., Drummond G.S., and Abraham N.G. Downregulation of the human heme oxygenase gene by glucocorticoids and identification of 56b regulatory elements. Biochem Biophys Res Commun 218 3 (1996) 759-765
59. Franchimont D., Galon J., Gadina M., Visconti R., Zhou Y., Aringer M., et al. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J Immunol 164 4 (2000) 1768-1774
60. Stocklin E., Wissler M., Gouilleux F., and Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383 6602 (1996) 726-728
61. Stoecklin E., Wissler M., Moriggl R., and Groner B. Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription. Mol Cell Biol 17 11 (1997) 6708-6716
62. Biola A., Lefebvre P., Perrin-Wolff M., Sturm M., Bertoglio J., and Pallardy M. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer activator of transcription 5) but not AP-1. Mol Endocrinol 15 7 (2001) 1062-1076
63. Hermoso M.A., Matsuguchi T., Smoak K., and Cidlowski J.A. Glucocorticoids and tumor necrosis factor alpha cooperatively regulate Toll-like receptor 2 gene expression. Mol Cell Biol 24 11 (2004) 4743-4756
64. Moriggl R., Berchtold S., Friedrich K., Standke G.J., Kammer W., Heim M., et al. Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells. Mol Cell Biol 17 7 (1997) 3663-3678
65. Reily M.M., Pantoja C., Hu X., Chinenov Y., and Rogatsky I. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J 25 1 (2006) 108-117
66. Aurrekoetxea-Hernandez K., and Buetti E. Transforming growth factor beta enhances the glucocorticoid response of the mouse mammary tumor virus promoter through Smad and GA-binding proteins. J Virol 78 5 (2004) 2201-2211
67. Song C.Z., Tian X., and Gelehrter T.D. Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3. Proc Natl Acad Sci USA 96 21 (1999) 11776-11781
68. Chen R., Burke T.F., Cumberland J.E., Brummet M., Beck L.A., Casolaro V., et al. Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter. J Immunol 164 2 (2000) 825-832
69. Nishio Y., Isshiki H., Kishimoto T., and Akira S. A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction. Mol Cell Biol 13 3 (1993) 1854-1862
70. Waterman W.R., Xu L.L., Tetradis S., Motyckova G., Tsukada J., Saito K., et al. Glucocorticoid inhibits the human pro-interleukin lbeta gene (ILIB) by decreasing DNA binding of transactivators to the signal-responsive enhancer. Mol Immunol 43 7 (2006) 773-782
71. Prefontaine G.G., Lemieux M.E., Giffin W., Schild-Poulter C., Pope L., LaCasse E., et al. Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. Mol Cell Biol 18 6 (1998) 3416-3430
72. Wyszomierski S.L., Yeh J., and Rosen J.M. Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol Endocrinol 13 2 (1999) 330-343
73. Tirard M., Jasbinsek J., Almeida O.F., and Michaelidis T.M. The manifold actions of the protein inhibitor of activated STAT proteins on the transcriptional activity of mineralocorticoid and glucocorticoid receptors in neural cells. J Mol Endocrinol 32 3 (2004) 825-841
74. Roth M., and Black J.L. Transcription factors in asthma: are transcription factors a new target for asthma therapy. Curr Drug Targets 7 5 (2006) 589-595
75. Croxtall J.D., Choudhury Q., and Flower R.J. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription- independent mechanism. Br J Pharmacol 130 2 (2000) 289-298
76. Croxtall J.D., van Hal P.T., Choudhury Q., Gilroy D.W., and Flower R.J. Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells. Br J Pharmacol 135 2 (2002) 511-519
77. Hafezi-Moghadam A., Simoncini T., Yang Z., Limbourg F.P., Plumier J.C., Rebsamen M.C., et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8 5 (2002) 473-479
78. Limbourg F.P., Huang Z., Plumier J.C., Simoncini T., Fujioka M., Tuckermann J., et al. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest 110 11 (2002) 1729-1738
79. Evans S.J., Searcy B.T., and Moore F.L. A subset of kappa opioid ligands bind to the membrane glucocorticoid receptor in an amphibian brain. Endocrinology 141 7 (2000) 2294-2300
80. Powell C.E., Watson C.S., and Gametchu B. Immunoaffinity isolation of native membrane glucocorticoid receptor from S-49++ lymphoma cells: biochemical characterization and interaction with Hsp 70 and Hsp 90. Endocrine 10 3 (1999) 271-280
81. Peppel K., Vinci J.M., and Baglioni C. The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J Exp Med 173 2 (1991) 349-355
82. Smoak K., and Cidlowski J.A. Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling. Mol Cell Biol 26 23 (2006) 9126-9135
83. Lasa M., Abraham S.M., Boucheron C., Saklatvala J., and Clark A.R. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22 22 (2002) 7802-7811
84. Abraham S.M., Lawrence T., Kleiman A., Warden P., Medghalchi M., Tuckermann J., et al. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med 203 8 (2006) 1883-1889
85. Shuto T., Imasato A., Jono H., Sakai A., Xu H., Watanabe T., et al. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem 277 19 (2002) 17263-17270
86. Poon M., Liu B., and Taubman M.B. Identification of a novel dexamethasone-sensitive RNA- destabilizing region on rat monocyte chemoattractant protein 1 mRNA. Mol Cell Biol 19 10 (1999) 6471-6478
87. Staples K.J., Bergmann M.W., Barnes P.J., and Newton R. Evidence for post-transcriptional regulation of interleukin-5 by dexamethasone. Immunology 109 4 (2003) 527-535
88. Amsterdam A., Sasson K., and Newton R. Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol 64 5-6 (2002) 843-850
89. Herr I., Gassler N., Friess H., and Buchler M.W. Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids. Apoptosis 12 2 (2006) 271-291
90. Distelhorst C.W. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 9 1 (2002) 6-19
91. Greenstein S., Ghias K., Krett N.L., and Rosen S.T. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res 8 6 (2002) 1681-1694
92. Huang S.T., and Cidlowski J.A. Phosphorylation status modulates Bcl-2 function during glucocorticoid-induced apoptosis in T lymphocytes. FASEB J 16 8 (2002) 825-832
93. Herold M.J., McPherson K.G., and Reichardt H.M. Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 63 1 (2006) 60-72
94. Yoshikawa H., and Tasaka K. Suppression of mast cell activation by glucocorticoid. Arch Immunol Ther Exp (Warsz) 48 6 (2000) 487-495
95. Druilhe A., Letuve S., and Pretolani M. Glucocorticoid-induced apoptosishuman eosinophils: mechanisms of action. Apoptosis 8 5 (2003) 481-495
96. Schmidt M., Pauels H.G., Lugering N., Lugering A., Domschke W., and Kucharzik T. Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta. J Immunol 163 6 (1999) 3484-3490
97. Boor P.P., Metselaar H.J., Mancham S., Tilanus H.W., Kusters J.G., and Kwekkeboom J. Prednisolone suppresses the function and promotes apoptosis of plasmacytoid dendritic cells. Am J Transplant 6 10 (2006) 2332-2341
98. Giles K.M., Ross K., Rossi A.G., Hotchin N.A., Haslett C., and Dransfield I. Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac. J Immunol 167 2 (2001) 976-986
99. Atsuta J., Plitt J., Bochner B.S., and Schleimer R.P. Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids. Am J Respir Cell Mol Biol 20 4 (1999) 643-650
100. Cronstein B.N., Kimmel S.C., Levin R.I., Martiniuk F., and Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 89 21 (1992) 9991-9995
101. Miyamasu M., Misaki Y., Izumi S., Takaishi T., Morita Y., Nakamura H., et al. Glucocorticoids inhibit chemokine generation by human eosinophils. J Allergy Clin Immunol 101 1 Pt 1 (1998) 75-83
102. Schramm R., and Thorlacius H. Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoids. Inflamm Res 53 12 (2004) 644-652
103. Sewell W.A., Scurr L.L., Orphanides H., Kinder S., and Ludowyke R.I. Induction of interleukin-4 and interleukin-5 expression in mast cells is inhibited by glucocorticoids. Clin Diagn Lab Immunol 5 1 (1998) 18-23
104. Pype J.L., Dupont L.J., Menten P., Van Coillie E., Opdenakker G., Van Damme J., et al. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am J Respir Cell Mol Biol 21 4 (1999) 528-536
105. Schleimer R.P. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc 1 3 (2004) 222-230
106. Galon J., Franchimont D., Hiroi N., Frey G., Boettner A., Ehrhart-Bornstein M., et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16 1 (2002) 61-71
107. Blotta M.H., DeKruyff R.H., and Umetsu D.T. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol 158 12 (1997) 5589-5595
108. Agarwal S.K., and Marshall Jr. G.D. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res 21 3 (2001) 147-155
109. Cohen S., Tyrrell D.A., and Smith A.P. Psychological stress and susceptibility to the common cold. N Engl J Med 325 9 (1991) 606-612
110. Sainz B., Loutsch J.M., Marquart M.E., and Hill J.M. Stress-associated immunomodulation herpes simplex virus infections. Med Hypotheses 56 3 (2001) 348-356
111. Wiper-Bergeron N., Wu D., Pope L., Schild-Poulter C., and Hache R.J. Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J 22 9 (2003) 2135-2145
112. Grange T., Roux J., Rigaud G., and Pictet R. Cell-type specific activity of two glucocorticoid responsive units of rat tyrosine aminotransferase gene is associated with multiple binding sites for C/EBP a novel liver-specific nuclear factor. Nucleic Acids Res 19 1 (1991) 131-139
113. Rigaud G., Roux J., Pictet R., and Grange T. In vivo footprinting of rat TAT gene: dynamic interplay between the glucocorticoid receptor and a liver-specific factor. Cell 67 5 (1991) 977-986
114. Beurton F., Bandyopadhyay U., Dieumegard B., Barouki R., and Aggerbeck M. Delineation of the insulin-responsive sequence in the rat cytosolic aspartate aminotransferase gene: binding sites for hepatocyte nuclear factor-3 and nuclear factor I. Biochem J 343 Pt 3 (1999) 687-695
115. Yoshiuchi I., Shingu R., Nakajima H., Hamaguchi T., Horikawa Y., Yamasaki T., et al. Mutation/polymorphism scanning of glucose-6-phosphatase gene promoter in noninsulin-dependent diabetes mellitus patients. J Clin Endocrinol Metab 83 3 (1998) 1016-1019
116. Ruppert S., Boshart M., Bosch F.X., Schmid W., Fournier R.E., and Schutz G. Two genetically defined trans-acting loci coordinately regulate overlapping sets of liver-specific genes. Cell 61 5 (1990) 895-904
117. Dostert A., and Heinzel T. Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Curr Pharm Des 10 23 (2004) 2807-2816
118. Radoja N., Komine M., Jho S.H., Blumenberg M., and Tomic-Canic M. Novel mechanism of steroid action in skin through glucocorticoid receptor monomers. Mol Cell Biol 20 12 (2000) 4328-4339
119. Anstead G.M. Steroids, retinoids, and wound healing. Adv Wound Care 11 6 (1998) 277-285
120. Chrysis D., Zaman F., Chagin A.S., Takigawa M., and Savendahl L. Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-phosphatidylinositol 3′-kinase signaling pathway. Endocrinology 146 3 (2005) 1391-1397
121. Ou X.M., Storring J.M., Kushwaha N., and Albert P.R. Heterodimerization of mineralocorticoid and glucocorticoid receptors at a novel negative response element of the 5-HT1A receptor gene. J Biol Chem 276 17 (2001) 14299-14307
122. Wissink S., Meijer O., Pearce D., van Der Burg B., and van Der Saag P.T. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J Biol Chem 275 2 (2000) 1321-1326
123. De Bosscher K., Vanden Berghe W., Beck I.M., Van Molle W., Hennuyer N., Hapgood J., et al. A fully dissociated compound of plant origin for inflammatory gene repression. Proc Natl Acad Sci USA 102 44 (2005) 15827-15832
124. De Bosscher K., Vanden Berghe W., and Haegeman G. Cross-talk between nuclear receptors nuclear factor kappaB. Oncogene 25 51 (2006) 6868-6886
125. Barnes P.J. Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment. Expert Opin Ther Targets 9 6 (2005) 1111-1121
126. Barnes P.J. Transcription factors in airway diseases. Lab Invest 86 9 (2006) 867-872
127. Catley M.C., Sukkar M.B., Chung K.F., Jaffee B., Liao S.M., Coyle A.J., et al. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle. Mol Pharmacol 70 2 (2006) 697-705
128. Cosio B.G., Tsaprouni L., Ito K., Jazrawi E., Adcock I.M., and Barnes P.J. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 200 5 (2004) 689-695
129. Adcock I.M., Lane S.J., Brown C.R., Lee T.H., and Barnes P.J. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med 182 6 (1995) 1951-1958
130. Bantel H., Domschke W., Schulze-Osthoff K., Kaskas B., and Gregor M. Abnormal activation of transcription factor NF-kappaB involved in steroid resistance in chronic inflammatory bowel disease. Am J Gastroenterol 95 7 (2000) 1845-1846
131. Bantel H., Schmitz M.L., Raible A., Gregor M., and Schulze-Osthoff K. Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness. FASEB J 16 13 (2002) 1832-1834
132. Lane S.J., Adcock I.M., Richards D., Hawrylowicz C., Barnes P.J., and Lee T.H. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. J Clin Invest 102 12 (1998) 2156-2164
133. Sousa A.R., Lane S.J., Cidlowski J.A., Staynov D.Z., and Lee T.H. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J Allergy Clin Immunol 105 5 (2000) 943-950